The Gross Margin of Shin Nippon Biomedical Laboratories Ltd (2395.T) is 52.33%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2025-03-31 | 52.33% |
| 2024-03-31 | 54.00% |
| 2023-03-31 | 52.00% |
| 2022-03-31 | 54.58% |
| 2021-03-31 | 49.99% |
| 2020-03-31 | 52.30% |
| 2019-03-31 | 39.45% |
| 2018-03-31 | 31.35% |
| 2017-03-31 | 25.28% |
| 2016-03-31 | 18.24% |